---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-017199"
form_type: "8-K"
ticker: "HSIC"
cik: "0001000228"
company_name: "HENRY SCHEIN INC"
filed_at: "2025-05-05T23:59:59+00:00"
generated_at: "2026-05-22T16:00:59.415385+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Henry Schein Q1 GAAP EPS $0.88 (+22% YoY); non-GAAP EPS $1.15 (+4.5%); maintains FY guidance

## Summary
- Q1 net sales $3.2B; constant currency sales up 1.4% (2.0% ex-PPE/COVID test kits).
- Global Distribution sales +0.8% constant currency; Medical +3.0%, Specialty +4.3%.
- Repurchased $161M of stock (~2.3M shares at avg $71.58); $718M remaining authorization.
- Restructuring costs $25M in Q1; expects annual run-rate savings at high end of $75M-$100M by end-2025.
- FY2025 guidance unchanged: non-GAAP EPS $4.80-$4.94, sales growth 2%-4%, mid-single digit EBITDA growth.

## SEC filing metadata
- accession: 0001140361-25-017199
- form_type: 8-K
- ticker: HSIC
- cik: 0001000228
- company_name: HENRY SCHEIN INC
- filed_at: 2025-05-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1000228/000114036125017199/0001140361-25-017199-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1000228/000114036125017199/hsic-20250505.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-017199
- JSON: https://secwatch.observer/filing/0001140361-25-017199.json
- Plain text: https://secwatch.observer/filing/0001140361-25-017199.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.